These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24993298)

  • 21. Association between
    Guo Y; Zhang Y; Tang X; Liu X; Xu H
    PeerJ; 2023; 11():e15181. PubMed ID: 37123013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk.
    Stefanic M; Rucevic I; Barisic-Drusko V
    Int J Dermatol; 2013 Jun; 52(6):705-10. PubMed ID: 23488577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.
    Hu W; Wang L; Chen B; Wang X
    Neurosci Lett; 2020 Jan; 717():134722. PubMed ID: 31877334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-10-1082A/G and -592C/A polymorphisms with risk of Parkinson's disease: a meta-analysis.
    Jin J; Wu P; Li W; Shi J; Chen J; Li R; Tan S
    Int J Neurosci; 2014 Nov; 124(11):852-8. PubMed ID: 24397502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between two α-2-macroglobulin gene polymorphisms and Parkinson's disease: a meta-analysis.
    Guo X; Tang P; Li X; Chong L; Zhang X; Li R
    Int J Neurosci; 2016; 126(3):193-8. PubMed ID: 25495992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
    Raimondi S; Johansson H; Maisonneuve P; Gandini S
    Carcinogenesis; 2009 Jul; 30(7):1170-80. PubMed ID: 19403841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Lee YH; Song GG
    J Mot Behav; 2014; 46(1):59-66. PubMed ID: 24329127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5Apal, Taql, Fokl, and Bsml polymorphisms and the susceptibility of Behcet's disease: an updated meta-analysis.
    Wu M; Li L; Tian L; Liu D; Jian J; Zhou Y; Xu Y
    Immunol Res; 2022 Dec; 70(6):781-792. PubMed ID: 35849257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders.
    Geng J; Zhang J; Yao F; Liu X; Liu J; Huang Y
    Aging Clin Exp Res; 2020 Jan; 32(1):21-27. PubMed ID: 30863943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic association of RIT2 rs12456492 polymorphism and Parkinson's disease susceptibility in Asian populations: a meta-analysis.
    Lu Y; Liu W; Tan K; Peng J; Zhu Y; Wang X
    Sci Rep; 2015 Sep; 5():13805. PubMed ID: 26334395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis.
    Bagheri-Hosseinabadi Z; Imani D; Yousefi H; Abbasifard M
    Clin Rheumatol; 2020 Dec; 39(12):3555-3569. PubMed ID: 32445089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: a meta-regression and updated meta-analysis.
    Zhai N; Bidares R; Makoui MH; Aslani S; Mohammadi P; Razi B; Imani D; Yazdchi M; Mikaeili H
    BMC Endocr Disord; 2020 Aug; 20(1):121. PubMed ID: 32771009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study.
    Thakkinstian A; D'Este C; Eisman J; Nguyen T; Attia J
    J Bone Miner Res; 2004 Mar; 19(3):419-28. PubMed ID: 15040830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
    Song GG; Lee YH
    Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis.
    Lu Y; Peng Q; Zeng Z; Wang J; Deng Y; Xie L; Mo C; Zeng J; Qin X; Li S
    J Neurol Sci; 2014 Jan; 336(1-2):161-8. PubMed ID: 24211060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association between VDR Gene Polymorphisms and Diabetic Retinopathy Susceptibility: A Systematic Review and Meta-Analysis.
    Zhang Y; Xia W; Lu P; Yuan H
    Biomed Res Int; 2016; 2016():5305282. PubMed ID: 27891515
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density.
    Eckstein M; Vered I; Ish-Shalom S; Shlomo AB; Shtriker A; Koren-Morag N; Friedman E
    Isr Med Assoc J; 2002 May; 4(5):340-4. PubMed ID: 12040821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of Parkinson's disease.
    Wang Y; Zhou M; Wang Y; Jiang D; Deng X
    J Neural Transm (Vienna); 2019 Nov; 126(11):1465-1470. PubMed ID: 31471711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.